Inhibitory effect of sesamolin on melanogenesis in B16F10 cells by in vitro and in silico analysis.
Melanin protects against the harmful effects of ultraviolet irradiation to the mammalian skin. However, melanin overproduction causes several esthetic problem like a melasma, freckle, age spot and chloasma. So, the development of anti-melanogenic agents is important for the prevention of serious hyperpigmentation diseases. This study evaluated the anti-melanogenic effect of sesamolin, a lignan compound isolated from sesame seeds, on melanogenesis induced by 3-isobutyl-1-methylxanthine in B16F10 melanoma cells using zymography, tyrosinase inhibitory activity, western blot, and reverse transcription polymerase chain reaction analysis. Also, docking simulations between sesamolin and tyrosinase were performed using Autodock vina, and the skin irritancy of sesamolin was predicted by quantitative structure-activity relationship (QSAR) analysis. Sesamolin significantly inhibited the expression of melanogenesis-related mRNA levels, as well as proteins such as tyrosinase and tyrosinase-related proteins 1 and 2. Sesamolin inhibitory activity was dose-dependent, and 50 µM sesamolin demonstrated the strongest competitive inhibition against intercellular tyrosinase and melanin synthesis without exerting cytotoxic effects. Tyrosinase docking simulations revealed that sesamolin (-6.5 kcal/mol) bound to the active site of tyrosinase more strongly than the positive control (arbutin, -5.7 kcal/mol). Sesamolin is a good candidate for melanogenic inhibition. However, sesamolin was predicted as a weak sensitizer by Derek EC3 prediction. It is necessary to confirm the safety of sesamolin as a cosmetic material in a biological skin toxicity experiment.